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Introduction
Cervical cancer (CC) is the second-most common female-specific carcinoma after breast cancer and accounts for approximately 8% of total cancer deaths in women worldwide [1] . CC, especially cervical adenocarcinoma, has a poor prognosis, with 5-year survival rates of only 30-40% or less for women with advanced-stage cancer [2] . Human papilloma virus (HPV) infection is the greatest risk factor for CC; however, many people with HPV infection do not develop CC, suggesting that additional factors are required for the induction and progression of CC. Several other contributing factors, including smoking, a weak immune system, and oral contraceptives, have been implicated, but not all of the factors are known.
In recent years, numerous epidemiologic studies have found that obesity, overweight, and serum lipid levels are risk factors for CC morbidity and mortality; these findings suggest that lipids are significantly associated with CC [3] [4] [5] . Dietary lipids, major nutritional components, are important determinants associated with the risk of cancer development. Nonetheless, human data regarding the association between lipid intake and cancer are conflicting, mainly depending on the type and quantity of lipids. High saturated fatty acid intake, mainly from animal sources, could increase cancer risk, especially breast cancer [6] . Polyunsaturated fatty acids, especially eicosapentaenoic acid and docosahexaenoic acid from fish oil, inhibit breast and colon tumor growth and metastasis [7, 8] . However, the role of monounsaturated fatty acids, primarily oleic acid (OA) (18:1 n-9) and its main dietary source, olive oil, in cancer development remain unclear. Experimental studies M A N U S C R I P T
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addressing the effects of olive oil on cancer progression have been conducted mainly in breast cancer models, and olive oil seems to have protective effects [7, 9] . However, inconsistent data have also been reported, which showed a tumor-enhancing role of OA in many cancer types [10] [11] [12] [13] . So far, the role of OA in cancer is uncertain and has attracted much attention in recent years.
It is well known that cells can take up fatty acid by passive diffusion and by receptor-mediated mechanisms involving several fatty acid transporters, of which the fatty acid translocase CD36 is the best characterized [14] . CD36 is an integral transmembrane glycoprotein expressed in various tissues, where it is involved in high-affinity uptake of long-chain fatty acids (LCFAs), mainly oleate and palmitate [15] . CD36 expression is strongly induced by LCFAs, which, in turn, mediate lipid metabolism and may also initiate signal transduction. There is increasing evidence that alterations in lipid metabolism are strongly associated with tumorigenesis; these alterations can regulate cancer cell proliferation, differentiation, metastasis and survival [16] . A possible emerging role of CD36 in cancer has been proposed recently.
Glioblastoma stem cells with high CD36 expression can enhance self-renewal and tumor initiation capacity [17] . A subpopulation of leukemic cancer stem cells with CD36-positive expression was shown to have unique metabolic properties and evade chemotherapy [18] . CD36 + oral carcinoma cells were unique in their ability to initiate metastasis relying on changes in lipid metabolism [19] .
In this study, we sought to determine the effects of a high fat diet enriched with olive oil on the development of experimental CC and explore the underlying M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT molecular mechanisms. High olive oil diet feeding enhanced CC progression, and then we examined the regulation of CD36 by OA. Furthermore, we explored the role of CD36 and its downstream signaling pathways in OA-induced tumor growth. Based on this study, we suggest that CD36 might be a therapeutic target for CC patients with lipid disorders.
Materials and methods

Animal models
Animal care and experimental procedures were performed with approval from the Animal Care Committee of Chongqing Medical University. All animal studies were conducted in accordance with institutional guidelines for the care and use of experimental animals. Four-week-old BALB/c-nu/nu nude mice were assigned randomly to receive a normal diet (10% kcal from fat) or a high olive oil diet (45% kcal from fat) purchased from Htpharma Technology Development Co., Ltd. (Beijing, China). The mice were inoculated subcutaneously in their left flanks with 5×10 6 HeLa cells. Tumor growth was measured every 3 days, and the volumes of the xenograft tumors were calculated using the following standard formula: length × width × width × 0.5. In another experiment, HeLa cells were injected into the mice via their tail veins (1× 10 6 cells) to establish a metastatic model as described previously [20] .
Cell culture
HeLa cells were cultured in high glucose DMEM containing 10% fetal bovine serum (FBS). HeLa cell line was authenticated by short tandem repeat analysis. The The transfected cells were then selected with puromycin. All lentiviruses were purchased from Shanghai Genechem Co., Ltd. (Shanghai, China).
Cell proliferation assay
HeLa cells were seeded in 96-well plates at a density of 5000 cells/well. After 24 h, the cells were incubated in serum-free medium for 12 h. Then, the cells were subjected to OA loading (from 0 to 100 µM) for different times. All experiments were carried out in serum-free DMEM medium containing 0.2% fatty acid-free BSA. The OD values were measured at 450 nm after incubation with CCK-8 reagent for 2 h at 37℃.
Cell cycle analysis
HeLa cells were treated with or without OA for 48 h. Then, the cell cycle analysis was performed using flow cytometry after RNase A treatment and PI staining.
Transwell assays
For the transwell migration assays, HeLa cells in the upper chamber were treated with or without different concentrations of OA, while DEME containing 10% FBS was added to the lower chambers. For the transwell invasion assays, the upper M A N U S C R I P T
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membrane was coated with 40 µl Matrigel (BD Biosciences) in advance. After incubation, the cells were fixed and stained with trypan blue.
Wound healing
HeLa cells were seeded in 24-well plates, and the monolayer was scratched with a pipette tip. After that, the cells were treated with or without OA for 0-72 h. Then, the wound areas were quantified using Image J software.
Colony formation assay
HeLa cells were plated in 6-well plates at a density of 4000 cells/well with medium containing 10% FBS. Then, the cells were treated with or without OA (5 µM) for 2 weeks. Colonies were fixed and stained with a 0.1% crystal violet solution and counted grossly.
Histology and immunohistochemistry (IHC) analysis
HE staining and IHC analysis have been described previously [21] . The following primary antibodies were used: anti-CD36 (1:800, Novus), anti-PCNA (1:8000, CST), anti-vimentin (1:100, CST) and anti-E-cadherin (1:500, CST).
Real-time quantitative PCR (qPCR)
Total RNA was extracted using TRIzol reagent (Takara) and reverse transcribed into cDNA. Next, the cDNA products were subjected to 2-step PCR amplification.
The relative expression of the genes was analyzed using the 2-∆∆Ct method, and β-actin was used as the internal reference gene.
Western blot analysis
Total protein was extracted using RIPA lysis buffer. Western blotting was M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
performed as previously described [21] . The following primary antibodies were used:
anti-JNK, anti-P-JNK, anti-Src, anti-P-Src, anti-ERK, anti-P-ERK, anti-AKT, anti-P-AKT, anti-AMPK, and anti-P-AMPK (1:1000, CST); anti-CD36 (1:2000, Novus); and anti-β-actin (1:5000, Bioss). The protein bands were semi-quantified by ImageJ software.
Statistical analysis
CC clinical data were downloaded from The Cancer Genome Atlas (TCGA)
database. The chi-square test was applied to determine the association between CD36 expression and the CC clinicopathological parameters. A survival analysis was conducted to compare the overall survival rates using Kaplan-Meier survival curves with log-rank tests.
Statistical analyses were performed using Student's t test when only two groups were compared, and one-way analysis of variance followed by Turkey's multiple comparison test was used for three groups. All data are presented as the mean ± SEM, and P <0.05 was considered significant.
Results
High olive oil diet aggravates CC growth and metastasis in a mouse xenograft model
Mice were divided into two groups and fed either a normal chow diet (10% kcal from fat) or a high olive oil diet (45% kcal from fat), and tumor growth was monitored for 40 days. Mice in the olive oil diet group had considerably greater tumor M A N U S C R I P T
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growth than the control group, which included 1 mouse with no tumor ( Fig. 1 A) .
Consistently, both the sizes and weights of the xenograft tumors were increased more than 6-fold in the olive oil diet-fed mice at the end of the experiment ( Fig. 1 B, C) . As the primary tumor did not metastasize, we established a metastasis model by injecting
HeLa cells into the tail veins of the mice. Approximately 40 days later, the mice started to lose weight and were sacrificed. We observed the formation of tumor metastases in only the liver, while other distant metastases were not observed. Mice in the olive oil diet group had a higher metastasis incidence (4 in 10 mice) than mice in the normal group (1 in 11 mice) ( Fig. 1 D) . Significant increases in the size of the metastatic nodules were also found in mice fed the olive oil diet ( Fig. 1 E) .
OA promotes cell proliferation and migration
As the main component of olive oil is OA (up to 83%), we tested the modulation of cell function by OA in vitro. Cell viability and proliferation were analyzed using CCK-8 assays. No pharmaceutical toxicity was observed for 50 µM OA treatment ( Fig. 2 A) , and low concentrations of OA stimulated HeLa cell proliferation in a doseand time-dependent manner ( Fig. 2B, C) . A cell cycle analysis showed that the percentage of cells in S phase was increased, and that of cells in G2 phase was decreased by OA treatment (Fig. 2 D) . Additionally, the OA-treated cells formed a higher number of colonies than the control cells ( Fig. 2 E) , which revealed the improved survival and proliferative capacity of OA-incubated cells. In addition, cell migration and invasion ability were also significantly increased by OA in a dose-dependent manner (Fig. 2 F, G) . These data demonstrated that OA has M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
tumor-promoting effects in vitro.
CD36 expression was positively correlated with tumor progression
The xenograft tumors were then subjected to IHC analysis. We found significantly more PCNA-positive tumor cells, accompanied by higher CD36-membrane expression, in the tumors from the olive oil diet-fed mice than in those from the control mice ( Fig. 3 A) . Meanwhile, the mRNA and total protein expression of CD36 was increased by high olive oil diet feeding ( Fig. 3 B, C) . In vitro, OA treatment also elevated total and membrane expression of CD36 ( Fig. 3 CD36 expression was associated with a high risk of poor prognosis (HR=1.890, 95% CI 1.051 to 3.398) ( Fig. 3 I) . These data suggest that CD36 may participate in the pathogenesis of CC progression.
CD36 overexpression promotes tumor growth and metastasis in vitro and in vivo
To determine the effects of CD36 on experimental tumor growth, we constructed a stable HeLa cell line with CD36 overexpression that was confirmed by Western blot Fig. S1B,C) . As shown in Fig. 4 A-C, CD36 overexpression increased cell proliferation and migration similar to OA. Consistent with the in vitro results, CD36 overexpression enhanced subcutaneous xenograft tumor growth in mice ( Fig. 4 D-F) . The IHC examination revealed that higher CD36 expression was associated with tumor cell proliferation and invasion, as evidenced by increased PCNA and vimentin expression and decreased E-cadherin expression ( Fig. 4 G, H) .
These experimental data confirmed the role of CD36 in tumor progression.
CD36 suppression blocks the tumor-stimulating effects of OA
Sulfo-N-succinimidyl oleate (SSO), an analogue of OA, specifically and irreversibly binds to CD36 and inhibits fatty acid uptake by CD36. We next determined the effects of SSO on cellular function. As expected, SSO pretreatment attenuated the cell proliferation and migration that was induced by OA ( Fig. 5A-D) .
Then, we silenced the expression of CD36 by shRNA lentiviral transfection and the efficiency of and invasion ( Fig. 6D, E ). In addition, knockdown of CD36 failed to inhibit the proliferation and migration of SU6656-treated cells (Fig. 6F) . These results suggest OA-mediated CD36 involved in tumor pathogenesis through the Src/ERK1/2 pathway.
Discussion:
The Mediterranean diet, characterized by a high consumption of olive oil, which is considered on top of the list of "nutraceutical", provides health benefit effects especially by reducing major cardiovascular risk events [22, 23] . There has been growing interests regarding the possible role of olive oil in cancer prevention and M A N U S C R I P T
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treatment. Although a large number of human studies have shown increased fat intake is positively associated with cancer risk, the Mediterranean diet seems to have protective effects [24] . Numerous epidemiological studies have suggested a favorable effect of the Mediterranean diet on cancer morbidity reduction, especially breast cancer and colon cancer [7, 25] . In addition, prospective, cohort, and epidemiological studies have shown an inverse association between dietary monounsaturated fatty acids, such as OA, and the risk of cancer, including breast and liver cancer [26, 27] .
However, other studies have generated conflicting results, rendering the human studies on the effects of dietary olive oil or OA on cancer inconclusive [6, [27] [28] [29] [30] .
These conflicting results may be explained partly by the complexity of the interactions between genetic and environmental factors. However, few experimental studies have addressed the role of olive oil and OA in cancer genesis, and many questions remain to be explored. In the present study, a high olive oil diet did not protect nude mice from CC xenograft growth and metastasis; rather, this diet had a tumor-enhancing effect. Similarly, OA stimulated HeLa cell proliferation, migration, and invasion in vitro. Our results are consistent with the study from Vinciguerra et al.,
which showed a positive association between dietary OA and hepatoma progression.
OA is a functional molecule that exerts a variety of effects on cell growth, cell proliferation, epithelial to mesenchymal transition, cell migration, and angiogenesis.
Cancer cells rely mainly on fatty acids for membrane proliferation, energy storage, and signaling molecule generation. In addition, fatty acids influence cancer development by modulating signaling pathways involved in cell transformation and M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT tumorigenesis [7] . It has been widely described that fatty acids can directly bind to various nuclear receptors (LXR, PPAR and RXR) to activate their target gene transcription. Furthermore, fatty acids, such as OA, can active membrane receptors, e.g. epidermal growth factor receptor (EGFR) and GPR40 proteins, which are critical regulators of mitogenic cell signaling [31, 32] . In addition, OA can modulate the activity of PKC, AMPK, MMP9 and PLC, as well as the gene expression of Her-2/neu and PTEN, which are involved in carcinogenesis [10, 33, 34] . Here, we showed a novel regulatory role of OA in up-regulating the mRNA and protein expression of the membrane receptor CD36, which may be critical for the OA-mediated tumor-enhancing effects.
Metabolic reprogramming has been recognized as a new hallmark of tumorigenesis. Metabolomics screening of CC patients has identified systemic changes in lipid metabolites, indicating a potential link between lipid metabolism and CC development [35, 36] . Deregulation of lipid metabolism can affect numerous cellular processes, including proliferation, survival, and differentiation of cancer cells [37] . Increased de novo fatty acid synthesis has emerged as a defining feature of cancer cells and has become an attractive cancer target [38, 39] . Aside from de novo synthesis, cancer cells may uptake fatty acids actively from the environment to sustain cell division and proliferation [39] . The fatty acid translocase CD36 is the best-characterized protein that mediates fatty acid uptake across the plasma membrane.
CD36, which is highly expressed in metastatic ovarian tumors, scavenges LCFA from neighboring adipocytes to sustain rapid tumor growth and metastasis [40] . The
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anti-proliferation effect of breast cancer cells by SCD1 inhibitor can be reversed by exogenous OA in a CD36-dependent pathway [41] . Additionally, CD36+ cancer stem cells, which have unique metabolic properties, have shown self-renewal, tumor initiation, chemotherapy resistance and metastatic activity [17] [18] [19] . In our study, However, how CD36 activates the Src tyrosine kinase is still not clear. According to previous reports, CD36 may not be directly associated with Src but may be indirectly mediated by the activation of other members of the Src family (Fyn, Lyn). However, further studies are required to elucidate this mechanism.
In conclusion, our study suggests that OA-induced CD36, by activating Src/ERK signaling pathway, could be a critical step in the development and progression of CC;
thus, CD36 may be a novel target for cancer therapy. 
Figure2. Effects of OA supplement on cell proliferation, migration and invasion.
HeLa cells were treated with or without OA at different concentrations for the 
